Role of Pro-Inflammatory and Regulatory Cytokines in Pathogenesis of Graves’ Disease in Association with Autoantibody Thyroid and Regulatory FoxP3 T-Cells

Authors: Dwitya Elvira, Eryati Darwin

Abstract:

Background: Graves’ disease (GD) is an autoimmune thyroid disease. Imbalance of Th1/Th2 cells and T-regulatory (Treg)/Th17 cells was thought to play pivotal role in the pathogenesis of GD. Treg FoxP3 produced TGF-β to maintain regulatory function, and Th17 cells produced IL-17 as cytokines that were thought in mediating several autoimmune diseases. The aim of this study is to assess the role of IL-17 and TGF-β in the pathogenesis of GD and to investigate its correlation with Thyroid Stimulating Hormone Receptor Antibody (TRAb) and Treg FoxP3 expression. Method: 30 GD patients and 27 age and sex-matched controls were enrolled in this study. Diagnosis of GD was based on clinical and biochemical of GD. Serum IL-17, TGF-β, TRAb, and FoxP3 were measured by enzyme-linked immunosorbent assay (ELISA). Data were analyzed by using SPSS 21.0 (SPSS Inc.). Spearman rank correlation test was used for assessment of correlation. The statistical significance was accepted as P<0.05. Result: There was no significant correlation between IL-17 and TGF-β serum with expression of FoxP3 level in GD, but there was significant correlation between TGF-β and TRAb serum level (P<0.05). Serum levels of IL-17 and TGF-β were found to be elevated in patient group compared to control, where mean values of IL-17 were 14.43±2.15 pg/mL and TGF-β were 10.44±3.19 pg/mL in patients group; and in control group, level of IL-17 were 7.1±1.45 pg/mL and TGF-β were 4.95±1.35 pg/mL. Conclusion: Serum Il-17 and TGF-β were elevated in GD patients that reflect the role of inflammatory and regulatory cytokines activation in pathogenesis of GD. There was significant correlation between TGF-β and TRAb, revealing that Treg cytokines may play a role in pathogenesis of GD.

Keywords: IL-17, TGF-β, FoxP3, Graves’ disease.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1128877

References:

[1] Zhao S, Pan C, Cao H, Han B, Shi JY, Liang J Et al. Association of the CTLA4 gene with Graves’ disease in the Chinese Han population. Plos ONE. 2010;5(3):1-10.
[2] Wang H, Zhao S, Tang X, Li Jingyuan, Zou P Et al. Changes of regulatory T cells in Graves disease. Journal of Huazhong University of Science and Technology. 2006;26(5):545-547.
[3] Li X, Qi Y, Ma X, Huang F, Guo H, Jiang X. Chemokine (C-C Motif) ligand 20, a potential biomarker for Graves’ disease, is regulated by osteopontin. Plos ONE. 2013;8(5):1-8.
[4] Zha B, Wang L, Liu X, Liu J, Chen Z, Xu J. Decrease in proportion of CD19+CD24hiCD27+B cells and impairment of their suppressive function in Graves’ disease. Plos ONE. 2012;7(11):1-10.
[5] Inoue N, Watanabe M, Morita M, Tomizawa R, Akamizu T, Tatsumi K. Association of functional polymorphisms related to the transcriptional level of FoxP3 with prognosis of autoimmune thyroid diseases. Clinical and Experimental Immunology. 2010;162:402-6.
[6] Jiang W, Zheng L, Xu L, Zhang Y, Liu X, Hu L, Wang X. Association between FOXP3, FOXE1 gene polymorphisms and risk of differentiated thyroid cancer in Chinese Han population. Mol Biol. 2015;4(3):1-5.
[7] Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311-21.
[8] Esfahanian F, Naimi E, Doroodgar F, Jadali Z. Th1/Th2 cytokines in patients with Graves’ disease with or without ophtalmopathy. Iran J Allergy Asthma Immunol. 2013;12(8):168-75.
[9] Marazuela M. Garcia-Lopez MA, Figueroa-Vega N, de la FH, varado-Sanchez B, Monsivais Urenda A, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91(9):3639-46.
[10] Morshed SA, LAtif R, Davies TF. Delienating the autoimmune mechanisms in Graves’ disease. Immunol Res. 2012;54:191-203.
[11] Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. Journal of Interferon and Cytokine Research. 2011;31(10)1-13.
[12] Kim SE, Yoon JS, Kim KH, Lee SY. Increased serum interleukin-17 in Graves’ ophtalmopathy. Graefes Arch Clin Exp Ophtalmol. 2012;250(10):1521-6.
[13] Nanba T, Watanabe M, Inoue N, Iwatani Y. Increased of Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable GD. Thyroid. 2009;19(5):459-501.
[14] Zheng L, Ye P, Liu C. The role of the IL-23/IL17 axis in the pathogenesis of Graves’ disease. Endocrin J. 2013;60:591-7.
[15] Shi Y, Wang H, Su Z. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand J Immunol. 2010;72:250-55.
[16] Tabarkiewicz J, Pogoda K, Karczmarczyk A, Pozarowski P, Giannopoulus K. The role of IL-17 and Th17 lymphocytes in autoimmune diseases. Archivum Immunologiae et Therapiae Experimentalis. 2015;63(6):435-49.
[17] Roohi A, Tabrizi M, Abbasi F, Ataie-Jafari A, Nikbin B, Larijani B. Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls. BioMed Research International. 2014;1-8